Search: (WFRF:(Jansson Per Anders)) pers:(Johansson Lars)
> (2016) >
Effects of dapaglif...
Effects of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, and free omega-3 carboxylic acids on liver steatosis and hepatocyte damage biomarkers in Type 2 diabetes patients with non-alcoholic fatty liver disease
-
- Oscarsson, Jan (author)
- AstraZeneca R&D, Molndal, Sweden.
-
- Lundkvist, Per (author)
- Uppsala universitet,Klinisk diabetologi och metabolism
-
- Jansson, Per-Anders E. (author)
- Univ Gothenburg, Gothenburg, Sweden.
-
show more...
-
- Johansson, Lars (author)
- Antaros Med AB, Gothenburg, Sweden.
-
- Kvarnström, Mats (author)
- AstraZeneca R&D, Molndal, Sweden.
-
- Moris, Linda (author)
- Karolinska Trial Alliance, Stockholm, Sweden.
-
- Risérus, Ulf (author)
- Uppsala universitet,Klinisk nutrition och metabolism
-
- Lind, Lars (author)
- Uppsala universitet,Kardiologi
-
- Eriksson, Jan W. (author)
- Uppsala universitet,Klinisk diabetologi och metabolism
-
show less...
-
AstraZeneca R&D, Molndal, Sweden Klinisk diabetologi och metabolism (creator_code:org_t)
- 2016
- 2016
- English.
-
In: Hepatology. - 0270-9139 .- 1527-3350. ; 64:1 SUPP, s. 554A-554A
- Related links:
-
http://dx.doi.org/10...
-
show more...
-
https://urn.kb.se/re...
-
show less...
Subject headings
Close
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Gastroenterologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
-
Hepatology
(Search for host publication in LIBRIS)
To the university's database